-transparent.png){kind=logo}
This pilot study in limited-stage small-cell carcinoma of the lung using concurrent cisplatin (Platinol) and etoposide (VePesid) chemotherapy with radiotherapy has yielded a high complete response rate in 23 of 40 patients evaluable for response. Five of these responders have survived greater than 2 years off all therapy with a stable, high performance status. Median survival of all patients is 18 months. Toxicity has been acceptable, the most common being neutropenia. Radiation toxicities include 17 of 40 patients experiencing mild to moderate esophagitis, with one severe toxicity; and three of 40 patients developing mild to moderate radiation pneumonitis. The high complete remission observed with this program and the long tumor-free interval seen off maintenance therapy deserve further exploration. Toxicities appear only moderately greater than with other programs currently utilized.
J D McCracken, and
L M Janaki, and
S B Taylor, and
P G Giri, and
G B Weiss, and
W Gordon, and
R B Vance, and
J Crowley
June 1982,
Cancer,
J D McCracken, and
L M Janaki, and
S B Taylor, and
P G Giri, and
G B Weiss, and
W Gordon, and
R B Vance, and
J Crowley
February 1978,
Annals of internal medicine,
J D McCracken, and
L M Janaki, and
S B Taylor, and
P G Giri, and
G B Weiss, and
W Gordon, and
R B Vance, and
J Crowley
December 1980,
Cancer,
J D McCracken, and
L M Janaki, and
S B Taylor, and
P G Giri, and
G B Weiss, and
W Gordon, and
R B Vance, and
J Crowley
October 1994,
Japanese journal of clinical oncology,
J D McCracken, and
L M Janaki, and
S B Taylor, and
P G Giri, and
G B Weiss, and
W Gordon, and
R B Vance, and
J Crowley
November 1987,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J D McCracken, and
L M Janaki, and
S B Taylor, and
P G Giri, and
G B Weiss, and
W Gordon, and
R B Vance, and
J Crowley
August 2004,
Clinical cancer research : an official journal of the American Association for Cancer Research,
J D McCracken, and
L M Janaki, and
S B Taylor, and
P G Giri, and
G B Weiss, and
W Gordon, and
R B Vance, and
J Crowley
June 1993,
Cancer,
J D McCracken, and
L M Janaki, and
S B Taylor, and
P G Giri, and
G B Weiss, and
W Gordon, and
R B Vance, and
J Crowley
February 1995,
International journal of radiation oncology, biology, physics,
J D McCracken, and
L M Janaki, and
S B Taylor, and
P G Giri, and
G B Weiss, and
W Gordon, and
R B Vance, and
J Crowley
March 1991,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J D McCracken, and
L M Janaki, and
S B Taylor, and
P G Giri, and
G B Weiss, and
W Gordon, and
R B Vance, and
J Crowley
September 1988,
International journal of radiation oncology, biology, physics,
